# Adjunct Dexmedetomidine (Precedex®) Therapy Impact on Sedative and Analgesic Requirement

> **NCT00852046** · PHASE4 · WITHDRAWN · sponsor: **Avera McKennan Hospital & University Health Center**

## Conditions studied

- Sedation
- Analgesia

## Interventions

- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT00852046
- **Lead sponsor:** Avera McKennan Hospital & University Health Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-02
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI resigned.
- **Last updated:** 2011-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00852046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00852046, "Adjunct Dexmedetomidine (Precedex®) Therapy Impact on Sedative and Analgesic Requirement". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00852046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*